drugset / Trial / NCT00046995

Combination Chemotherapy in Treating Patients With Colon Cancer

NCT00046995 ↗

Phase 3 Unknown 800 enrolled Groupe Regional d'Etudes du Cancer Colorectal
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which schedule of chemotherapy is most effective in treating colon cancer. PURPOSE: Randomized phase III trial to compare different schedules of chemotherapy using carboplatin with fluorouracil and leucovorin in treating patients who have stage IIB or stage III colon cancer.

Timeline

Start
2001-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Leucovorin Small molecule — Intravenous
Subject fluorouracil Small molecule — Intravenous

Indications